Publicacións nas que colabora con Anxo Fernández Ferreiro (43)

2024

  1. Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models

    International Journal of Pharmaceutics, Vol. 652

  2. Clinical Effectiveness, Safety, and Compliance of Two Compounded Formulations of Tacrolimus Eye Drops: An Open-Label, Sequential Prospective Study

    International Journal of Molecular Sciences, Vol. 25, Núm. 18

  3. Preclinical characterization of endotoxin-induced uveitis models using OCT, PET/CT and proteomics

    International Journal of Pharmaceutics, Vol. 662

  4. Quantitative brain [18F]FDG PET beyond normal blood glucose levels

    NeuroImage, Vol. 300

  5. Safety and efficacy of personalised versus standard dosing of linezolid in patients with sepsis (SePkLin): a pragmatic, multicentre, randomised, controlled and superiority clinical trial protocol

    BMJ open, Vol. 14, Núm. 10, pp. e087465

2023

  1. Antifungal Combination Eye Drops for Fungal Keratitis Treatment

    Pharmaceutics, Vol. 15, Núm. 1

  2. Design and biopharmaceutical preclinical characterisation of a new thermosensitive hydrogel for the removal of gastric polyps

    International Journal of Pharmaceutics, Vol. 635, pp. 122706

  3. Efficacy and Safety of Inhaled Ethanol in Early-Stage SARS-CoV-2 Infection in Older Adults: A Phase II Randomized Clinical Trial

    Pharmaceutics, Vol. 15, Núm. 2

  4. Estudio farmacocinético de adalimumab intravítreo en un modelo de rata con uveítis mediante PET

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

2022

  1. Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence

    Pharmaceutics, Vol. 14, Núm. 10

  2. PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model

    International Journal of Pharmaceutics, Vol. 627

2021

  1. Anti-inflammatory effect of tacrolimus/hydroxypropyl-β-cyclodextrin eye drops in an endotoxin-induced uveitis model

    Pharmaceutics, Vol. 13, Núm. 10

  2. Base preclínica de sistemas lipídicos nanoestructurados (NLC) cargados con bevacizumab: diseño, desarrollo y caracterización fisicoquímica

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 87-89

  3. Ciclodextrinas oftálmicas: Estudios de irritación y permanencia en la superficie ocular mediante Tomografía por Emisión de Positrones

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 143-145

  4. Development and characterization of a tacrolimus/ hydroxypropyl-β-cyclodextrin eye drop

    Pharmaceutics, Vol. 13, Núm. 2, pp. 1-27

  5. Development and characterization of inhaled ethanol as a novel pharmacological strategy currently evaluated in a phase ii clinical trial for early-stage sars-cov-2 infection

    Pharmaceutics, Vol. 13, Núm. 3

  6. Diseño, desarrollo y caracterización de nanopartículas de PLGA cargadas con adalimumab

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 63-65

  7. Evaluación preclínica empleando imagen PET/CT de formulaciones impresas en 3D para el tratamiento de la Enfermedad Inflamatoria Intestinal

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 275-276

  8. Feasibility of Longitudinal Brain PET with Real-Time Arterial Input Function in Rats

    Molecular Imaging and Biology, Vol. 23, Núm. 3, pp. 350-360

  9. In situ forming and mucoadhesive ophthalmic voriconazole/HPβCD hydrogels for the treatment of fungal keratitis

    International Journal of Pharmaceutics, Vol. 597